DNM1L and Myocardial fibrosis: Polydatin treatment improved cardiac function, reduced myocardial fibrosis, inhibited mitochondrial fission mediated by dynamin-related protein 1 (DRP1), and activated PINK1–Parkin-dependent mitophagy in the myocardium.